• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    Neurocrine Biosciences Inc. (NBIX)

    -NasdaqGS
    35.99 Down 1.08(2.91%) Feb 5, 4:00PM EST
    Prev Close:37.07
    Open:36.70
    Bid:29.66 x 200
    Ask:35.70 x 500
    1y Target Est:70.86
    Beta:-0.041096
    Earnings Date:Feb 8 - Feb 12 (Est.)
    Day's Range:34.90 - 37.10
    52wk Range:32.67 - 58.46
    Volume:2,333,320
    Avg Vol (3m):1,039,820
    Market Cap:3.10B
    P/E (ttm):N/A
    EPS (ttm):-0.96
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NBIX

    Comparison

    Symbol% ChgMkt Cap
    NBIXDown 2.91%3.10B
    LLYUp 0.05%78.70B
    PFEUp 0.10%179.22B
    ABTDown 1.58%55.81B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):161.63
    Ex-Dividend Date:29-Dec-95

    Analysts

    Annual EPS Est (Dec-15) :-1.03
    Quarterly EPS Est (Dec-15) :-0.32
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):3.92

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Neurocrine Biosciences, Inc. discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback